Alpha Cognition Basic EPS 2020-2024 | ACOG
Alpha Cognition basic eps from 2020 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
| Alpha Cognition Annual Basic EPS |
| 2023 |
$-0.15 |
| 2022 |
$-0.18 |
| 2021 |
$-0.37 |
| 2020 |
$-0.13 |
| 2019 |
$-0.21 |
| Alpha Cognition Quarterly Basic EPS |
| 2024-06-30 |
$-0.01 |
| 2024-03-31 |
$-0.03 |
| 2023-12-31 |
$-0.07 |
| 2023-09-30 |
$-0.03 |
| 2023-06-30 |
$-0.03 |
| 2023-03-31 |
$-0.02 |
| 2022-12-31 |
$-0.05 |
| 2022-09-30 |
$-0.04 |
| 2022-06-30 |
$-0.05 |
| 2022-03-31 |
$-0.04 |
| 2021-12-31 |
$-0.01 |
| 2021-09-30 |
$-0.08 |
| 2021-06-30 |
$0.00 |
| 2021-03-31 |
$-0.28 |
| 2020-12-31 |
$-0.04 |
| 2020-09-30 |
$-0.03 |
| 2020-06-30 |
$-0.04 |
| 2020-03-31 |
$-0.02 |
| 2019-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.035B |
$0.000B |
|
Alpha Cognition Inc. is a clinical stage biopharmaceutical company. It involved in developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. Alpha Cognition Inc. is based in Vancouver, British Columbia.
|
